Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $94.64 -0.8%
Revenue Growth %: +9.6%
Financial Fact:
Taxes on Earnings: 178M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +9.6%
Financial Fact:
Taxes on Earnings: 178M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $10 billion versus the consensus estimate of $9.69 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- Microsoft stock target cut at Wolfe on higher capex estimates
- Baird Starts Abbott Labs (ABT) at Outperform, 'Set to Improve with Catalysts Ahead'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
